{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:25:24Z","timestamp":1790735124819,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T00:00:00Z","timestamp":1618876800000},"content-version":"am","delay-in-days":293,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012155","name":"National Institute for Medical Research Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012155","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.micpath.2020.104204","type":"journal-article","created":{"date-parts":[[2020,4,18]],"date-time":"2020-04-18T19:09:35Z","timestamp":1587236975000},"page":"104204","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Cannabinoid receptors and the proconvulsant effect of toxoplasmosis in mice"],"prefix":"10.1016","volume":"144","author":[{"given":"Mohammad-Mahdi","family":"Ghanbari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzieh","family":"Joneidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahere","family":"Kiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jalal","family":"Babaie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Sayyah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2020.104204_bib1","doi-asserted-by":"crossref","first-page":"105","DOI":"10.14411\/fp.2010.013","article-title":"Toxoplasmosis as a cause for behaviour disorders\u2013overview of evidence and mechanisms","volume":"57","author":"Fekadu","year":"2010","journal-title":"Folia Parasitol."},{"issue":"6","key":"10.1016\/j.micpath.2020.104204_bib2","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00281-012-0339-3","article-title":"Immune response and immunopathology during toxoplasmosis","volume":"34","author":"Dupont","year":"2012","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.micpath.2020.104204_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005447","article-title":"Neurons are the primary target cell for the brain-tropic intracellular parasite Toxoplasma gondii","volume":"12","author":"Cabral","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.micpath.2020.104204_bib4","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.pt.2017.04.001","article-title":"Brains and brawn: toxoplasma infections of the central nervous system and skeletal muscle","volume":"33","author":"Wohlfert","year":"2017","journal-title":"Trends Parasitol."},{"issue":"3","key":"10.1016\/j.micpath.2020.104204_bib5","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/pim.12173","article-title":"Persistence of Toxoplasma gondii in the central nervous system: a fine-tuned balance between the parasite, the brain and the immune system","volume":"37","author":"Blanchard","year":"2015","journal-title":"Parasite Immunol."},{"issue":"3","key":"10.1016\/j.micpath.2020.104204_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0090203","article-title":"Toxoplasmosis\u2014a global threat. Correlation of latent toxoplasmosis with specific disease burden in a set of 88 countries","volume":"9","author":"Flegr","year":"2014","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.micpath.2020.104204_bib7","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/pim.12157","article-title":"Toxoplasma gondii-induced neuronal alterations","volume":"37","author":"Parlog","year":"2015","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.micpath.2020.104204_bib8","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.neubiorev.2018.11.012","article-title":"Toxoplasmosis: a pathway to neuropsychiatric disorders","volume":"96","author":"Tyebji","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.micpath.2020.104204_bib9","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.schres.2018.05.007","article-title":"FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group. Latent toxoplasma infection in real-world schizophrenia: results from the national FACE-SZ cohort","volume":"201","author":"Fond","year":"2018","journal-title":"Schizophr. Res."},{"issue":"11","key":"10.1016\/j.micpath.2020.104204_bib10","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/nrmicro2858","article-title":"Modulation of innate immunity by Toxoplasma gondii virulence effectors","volume":"10","author":"Hunter","year":"2012","journal-title":"Nat. Rev. Microbiol."},{"issue":"11","key":"10.1016\/j.micpath.2020.104204_bib11","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1016\/j.ajpath.2018.07.007","article-title":"The neurotropic parasite Toxoplasma gondii induces sustained neuroinflammation with microvascular dysfunction in infected mice","volume":"188","author":"Estato","year":"2018","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.micpath.2020.104204_bib12","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s12974-018-1242-1","article-title":"Chronic Toxoplasma infection is associated with distinct alterations in the synaptic protein composition","volume":"15","author":"Lang","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.micpath.2020.104204_bib13","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.bbi.2014.08.001","article-title":"Toxoplasma gondii and anxiety disorders in a community-based sample","volume":"43","author":"Markovitz","year":"2015","journal-title":"Brain Behav. Immun."},{"issue":"8","key":"10.1016\/j.micpath.2020.104204_bib14","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1080\/20477724.2015.1117742","article-title":"The possible association between Toxoplasma gondii infection and risk of anxiety and cognitive disorders in BALB\/c mice","volume":"109","author":"Mahmoudvand","year":"2015","journal-title":"Pathog. Glob. Health"},{"key":"10.1016\/j.micpath.2020.104204_bib15","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1128\/IAI.00217-16","article-title":"Toxoplasma gondii infection in mice impairs long-term fear memory consolidation through dysfunction of the cortex and amygdala","volume":"84","author":"Ihara","year":"2016","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2020.104204_bib16","doi-asserted-by":"crossref","first-page":"6442","DOI":"10.1073\/pnas.0608310104","article-title":"Behavioral changes induced by Toxoplasma infection of rodents are highly specific to aversion of cat odors","volume":"104","author":"Vyas","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.micpath.2020.104204_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004801","article-title":"A unique dual activity amino acid hydroxylase in Toxoplasma gondii","volume":"4","author":"Gaskell","year":"2009","journal-title":"PloS One"},{"key":"10.1016\/j.micpath.2020.104204_bib18","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1242\/jeb.074716","article-title":"Toxoplasma gondii infection, from predation to schizophrenia: can animal behaviour help us understand human behaviour?","volume":"216","author":"Webster","year":"2013","journal-title":"J. Exp. Biol."},{"key":"10.1016\/j.micpath.2020.104204_bib19","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01428-15","article-title":"Toxoplasma gondii infections alter GABAergic synapses and signaling in the central ervous system","volume":"6","author":"Brooks","year":"2015","journal-title":"mBio"},{"key":"10.1016\/j.micpath.2020.104204_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exppara.2012.10.005","article-title":"Sex-dependent neurotransmitter level changes in brains of Toxoplasma gondii infected mice","volume":"133","author":"Gatkowska","year":"2013","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.micpath.2020.104204_bib21","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.bbr.2018.09.011","article-title":"From inflammatory reactions to neurotransmitter changes: implications for understanding the neurobehavioral changes in mice chronically infected with Toxoplasma gondii","volume":"359","author":"Wang","year":"2019","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.micpath.2020.104204_bib22","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.prp.2014.04.025","article-title":"Influence of toxoplasmosis on acetylcholinesterase activity, nitric oxide levels and cellular lesion on the brain of mice","volume":"210","author":"Tonin","year":"2014","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.micpath.2020.104204_bib23","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.exppara.2015.06.009","article-title":"Nitric oxide production increases during Toxoplasma gondii encephalitis in mice","volume":"156","author":"Dincel","year":"2015","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.micpath.2020.104204_bib24","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.nbd.2016.03.005","article-title":"Anti-NMDA receptor autoantibodies and associated neurobehavioral pathology in mice are dependent on age of first exposure to Toxoplasma gondii","volume":"91","author":"Kannan","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.micpath.2020.104204_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003525","article-title":"Toxoplasmosis and epilepsy-systematic review and meta analysis","volume":"9","author":"Ngoungou","year":"2015","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.micpath.2020.104204_bib26","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.seizure.2007.05.010","article-title":"Meta-analysis of three case controlled studies and an ecological study into the link between cryptogenic epilepsy and chronic toxoplasmosis infection","volume":"16","author":"Palmer","year":"2007","journal-title":"Seizure"},{"issue":"10","key":"10.1016\/j.micpath.2020.104204_bib27","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1002\/jnr.24036","article-title":"Contribution of dopamine neurotransmission in proconvulsant effect of Toxoplasma gondii infection in male mice","volume":"95","author":"Babaie","year":"2017","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.micpath.2020.104204_bib28","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.eplepsyres.2017.06.012","article-title":"Toxoplasmosis accelerates acquisition of epilepsy in rats undergoing chemical kindling","volume":"35","author":"Babaie","year":"2017","journal-title":"Epilepsy Res."},{"issue":"5","key":"10.1016\/j.micpath.2020.104204_bib29","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/sj.bjp.0705667","article-title":"Cannabinoids and neuroinflammation","volume":"141","author":"Walter","year":"2004","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.micpath.2020.104204_bib30","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.tips.2007.02.004","article-title":"The endocannabinoid system in targeting inflammatory neurodegenerative diseases","volume":"28","author":"Centonze","year":"2007","journal-title":"Trends Pharmacol. Sci."},{"issue":"3","key":"10.1016\/j.micpath.2020.104204_bib31","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1007\/s11481-013-9445-9","article-title":"Cannabinoid receptor 2: potential role in immunomodulation and neuroinflammation","volume":"8","author":"Rom","year":"2013","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"1","key":"10.1016\/j.micpath.2020.104204_bib32","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neuron.2005.11.027","article-title":"The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells","volume":"49","author":"Eljaschewitsch","year":"2006","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.micpath.2020.104204_bib33","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/sj.bjp.0707505","article-title":"Cannabinoid CB2 receptors in human brain inflammation","volume":"153","author":"Benito","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.micpath.2020.104204_bib34","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.neuropharm.2017.03.033","article-title":"New vistas on cannabis use disorder","volume":"124","author":"Melis","year":"2017","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.micpath.2020.104204_bib35","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/nrn3876","article-title":"Endocannabinoid signaling and the deteriorating brain","volume":"16","author":"Di Marzo","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.micpath.2020.104204_bib36","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/gbb.12253","article-title":"Developmental regulation of fear learning and anxiety behavior by endocannabinoids","volume":"15","author":"Lee","year":"2016","journal-title":"Gene Brain Behav."},{"issue":"5","key":"10.1016\/j.micpath.2020.104204_bib37","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/nrn3937","article-title":"Weeding out bad waves: towards selective cannabinoid circuit control in epilepsy","volume":"16","author":"Soltesz","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.micpath.2020.104204_bib38","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1124\/jpet.115.230151","article-title":"The pharmacological basis of cannabis therapy for epilepsy","volume":"357","author":"Reddy","year":"2016","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"Pt B","key":"10.1016\/j.micpath.2020.104204_bib39","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.yebeh.2016.11.006","article-title":"Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection","volume":"70","author":"Rosenberg","year":"2017","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.micpath.2020.104204_bib40","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1113\/jphysiol.2014.286633","article-title":"Chronic activation of CB2 cannabinoid receptors in the hippocampus increases excitatory synaptic transmission","volume":"593","author":"Kim","year":"2015","journal-title":"J. Physiol."},{"key":"10.1016\/j.micpath.2020.104204_bib41","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.eplepsyres.2016.08.011","article-title":"The cannabinoid CB2 receptor-specific agonist AM1241 increases pentylenetetrazole-induced seizure severity in Wistar rats","volume":"127","author":"de Carvalho","year":"2016","journal-title":"Epilepsy Res."},{"issue":"10","key":"10.1016\/j.micpath.2020.104204_bib42","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/j.eplepsyres.2014.10.001","article-title":"Role of CB2 receptors and cGMP pathway on the cannabinoid-dependent antiepileptic effects in an in vivo model of partial epilepsy","volume":"108","author":"Rizzo","year":"2014","journal-title":"Epilepsy Res."},{"issue":"1","key":"10.1016\/j.micpath.2020.104204_bib43","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1476-5381.1957.tb01354.x","article-title":"Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse","volume":"12","author":"Haley","year":"1957","journal-title":"Br. J. Pharmacol. Chemother."},{"key":"10.1016\/j.micpath.2020.104204_bib44","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.neulet.2018.05.042","article-title":"A role for peroxisome proliferator-activated receptor \u03b1 in anticonvulsant activity of docosahexaenoic acid against seizures induced by pentylenetetrazole","volume":"681","author":"Gavzan","year":"2018","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.micpath.2020.104204_bib45","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nchembio.129","article-title":"Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects","volume":"5","author":"Long","year":"2009","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.micpath.2020.104204_bib46","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.neuropharm.2013.05.034","article-title":"Synaptic plasticity alterations associated with memory impairment induced by deletion of CB2 cannabinoid receptors","volume":"73","author":"Garcia-Gutierrez","year":"2013","journal-title":"Neuropharmacology"},{"issue":"12","key":"10.1016\/j.micpath.2020.104204_bib47","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.1046\/j.1460-9568.1999.00847.x","article-title":"Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain","volume":"11","author":"Marsicano","year":"1999","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.micpath.2020.104204_bib48","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1006\/expr.1998.4301","article-title":"Toxoplasma gondii: kinetics of the dissemination in the host tissues during the acute phase of infection of mice and rats","volume":"90","author":"Zenner","year":"1998","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.micpath.2020.104204_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-4017(97)00227-6","article-title":"Toxoplasmosis of rats: a review, with considerations of their value as an animal model and their possible role in epidemiology","volume":"77","author":"Dubey","year":"1998","journal-title":"Vet. Parasitol."},{"issue":"2","key":"10.1016\/j.micpath.2020.104204_bib50","doi-asserted-by":"crossref","first-page":"E19","DOI":"10.3390\/pathogens6020019","article-title":"Neurophysiological changes induced by chronic Toxoplasma gondii infection","volume":"6","author":"Tedford","year":"2017","journal-title":"Pathogens"}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401020304915?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401020304915?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T03:41:56Z","timestamp":1774928516000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401020304915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":50,"alternative-id":["S0882401020304915"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2020.104204","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cannabinoid receptors and the proconvulsant effect of toxoplasmosis in mice","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2020.104204","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104204"}}